Life Sciences

Clade Therapeutics, Inc.

Year
2022

Clade's platform technology immune “cloaks” human pluripotent stem cells and their adult derivatives enabling the development of true ‘off-the-shelf’ cell transplantation therapies.

Company Status

Active

UArizona Inventors

College